Your session is about to expire
← Back to Search
Tango Dancing for Caregivers of Alzheimer's Patients
N/A
Waitlist Available
Led By Madeleine Hackney
Research Sponsored by Emory University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
45-65 years of age
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up before and after the intervention / control at least 20 times during 12 weeks
Awards & highlights
Study Summary
This trial will investigate whether a dance-based intervention can improve biomarkers, cognition, and mood in African American women who are at high risk for Alzheimer's disease.
Who is the study for?
This trial is for African American women aged 45-65 who are family caregivers of individuals with a 'probable AD' diagnosis from the Emory ADRC or Dr. Wharton's studies. It aims to help those at high risk for Alzheimer's disease.Check my eligibility
What is being tested?
The study compares the effects of adapted Tango dance sessions against educational lectures on inflammation, cognition, and mood in participants to see which method better supports their well-being.See study design
What are the potential side effects?
While not explicitly stated, potential side effects may include typical physical activity-related risks such as muscle soreness or strain from dancing. Emotional discomfort could arise during either intervention.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am between 45 and 65 years old.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ before and after the intervention / control at least 20 times during 12 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~before and after the intervention / control at least 20 times during 12 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in C-reactive protein
Change in Interleukin-10
Myxovirus Resistance Proteins
+8 moreSecondary outcome measures
Change in 30-second chair stand
Change in Brooks spatial memory test
Change in Buschke Selective Reminding Test
+14 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Adapted Tango DanceExperimental Treatment1 Intervention
20 improvisational, 90-minute adapted tango dance sessions over a 12-week period.
Group II: Educational ControlActive Control1 Intervention
Participants will take part in at least 20 educational lectures offered twice per week over 12 weeks.
Find a Location
Who is running the clinical trial?
US Department of Veterans AffairsFED
868 Previous Clinical Trials
487,830 Total Patients Enrolled
Emory UniversityLead Sponsor
1,638 Previous Clinical Trials
2,560,472 Total Patients Enrolled
Madeleine HackneyPrincipal InvestigatorSchool Of Medicine, Emory University
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My parent was likely diagnosed with Alzheimer's disease.I am between 45 and 65 years old.
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Research Study Groups:
This trial has the following groups:- Group 1: Adapted Tango Dance
- Group 2: Educational Control
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger